New hearing implant sentio under study: could it help the deaf hear?

NCT ID NCT07161154

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will observe 100 adults who receive the Sentio bone conduction hearing system as part of their normal care. The device is implanted under the skin and sends sound vibrations through the skull to the inner ear. Researchers will track how often the device is used successfully, any complications, and whether hearing improves. The goal is to see how well the system works in real-world practice for people with various types of hearing loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Sentio transcutaneous bone conduction hearing system (device)

What this could lead to

If successful, this study could confirm that the Sentio device is a safe and effective option for people with certain types of hearing loss.

What could go wrong

This is an observational study, not a controlled trial, so results may be less definitive. It is also small (100 participants) and not yet recruiting, so findings are preliminary.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

conductive hearing loss disorder deafness, unilateral hearing loss disorder Hearing Loss, Conductive hearing loss, mixed conductive-sensorineural

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••